Form D · Biotechnology
eLum Technologies, Inc.
Fremont, CA · CIK 0001685614
Offering snapshot reported Apr 21, 2020 · SEC filing
- Reported sold
- $1.98M Offering amount: $2.6M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 15, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 21, 2020 | Initial | $1,978,058 | No comparison | 22 | SEC filing |
| Apr 16, 2019 | Initial | $1,005,000 | No comparison | 19 | SEC filing |
| Jun 21, 2017 | Initial | $4,347,893 | No comparison | 35 | SEC filing |
| Oct 3, 2016 | Initial | $660,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-365414
Source: Form D, filed Apr 21, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Noelle Bagnall | Executive |
| Rodolfo Bellesi | Director |
| Ronald Bracken | Executive |
| John D'orazio | Director |
| Dr. Ricardo Hanel | Director |
| Jed Johnson | Executive |
| Ross Kayuha | Director, Executive |
| Flavio Lobato | Director |
| Dr. Peter Kim Nelson | Director |
| Quang Tran | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
47745 Fremont Blvd.
Fremont, CA, 94538
Fremont, CA, 94538